KDM1A and metabolic disease: However, it is undeniable that LSD1 is an important target for regulating the transformation of adipose tissue, and LSD1 can indeed become an important target for the treatment of obesity-related metabolic diseases, providing some new ideas for improving the pathophysiological state related to adipose tissue transformation, such as diabetes and atherosclerosis.